Clear kit identification improves efficiency and ensures accurate sample collection. Our redesigned kits feature labeling on all sides for quick identification in busy clinical settings.
Learn more: https://t.co/s1fPjRElYU
#Genomics#PatientFirst
Great evening connecting with customers and partners at our WGS education dinner in Baltimore. Advancing a genome-first approach can help shorten the rare disease diagnostic journey and deliver earlier insights for clinicians.
Learn more: https://t.co/L356bE7O4B
#Genomics
Genome sequencing is reshaping rare disease care. At the BCBS CareSourcing CAG Meeting, Leah Campbell, MS, CGC, will discuss how optical genome mapping & long-read sequencing expand WGS to deliver clearer answers for patients.
Join the session to learn more!
#BCBS#Genome
Happy Father’s Day from Baylor Genetics!
To the dads and father figures who show up with care, strength, and compassion, thank you for all you do for your families, today and every day.
#FathersDay
For #mitochondrial disease, the path to answers can be complex. At @umdf#MitoMed2026, our team connected with leaders across the community and shared insights on diagnostic challenges & the role of WGS in improving clarity.
Learn more: https://t.co/1TwvqgsO1U
Today, we honor Juneteenth - a celebration of freedom, resilience, and progress.
Juneteenth serves as a reflection on history and a reminder of the importance of continuing to advance equity, inclusion, and access to care for all communities.
#Juneteenth
Building a diagnosis takes true partnership. Trust is built through consistency and transparency, especially when guiding providers through complex results with confidence. Delivering results is only part of the work & supporting the decisions that follow is just as critical.
In a study of 1,498 infants with cardiac indications who underwent rWGS, 1 in 4 critically ill infants received at least one genetic diagnosis, reinforcing rWGS as a first-tier diagnostic tool to deliver timely answers for infants: https://t.co/zP1biyWK2S
#RareDisease
We’re heading to UMDF Mitochondrial Medicine 2026!
Our team is looking forward to connecting with clinicians, researchers, advocates, and industry leaders dedicated to advancing mitochondrial disease research, diagnosis, and patient care.
#MitoMed2026#Mitochondrial
Genome sequencing is becoming the standard for rare disease diagnosis.
Leading guidelines now support it as a first-line test—helping deliver faster answers with a more complete genetic picture. Learn more: https://t.co/1TwvqgsO1U
#GenomeSequencing#RareDisease
Genetic testing isn’t one-size-fits-all.
As Dr. April Adams shares, the genome is often the first step, but tools like RNA Sequencing can help complete the picture for some patients.
Advancing diagnosis means applying the right tools at the right time.
#GenomeSequencing
Great conversations at the #NSGC Innovation Summit. Our team was proud to engage with genetic counseling & industry leaders on priorities shaping genomic care.
Learn how Baylor Genetics is expanding what’s possible in genomics:
https://t.co/49HZvRUNLt
#Genomics#GeneChat
Whole genome sequencing can reveal the genetic drivers of disease, but inconclusive results need the right next step. Targeted RNA Sequencing helps clarify variant impact, reducing uncertainty & supporting confident clinical decisions. https://t.co/e0jfQQZwkD
#RNASeq
We’re joining the NSGC Industry Council to deepen collaboration with the genetic counseling community and help shape the future of genomic care.
Looking ahead to the Innovation Summit and continued progress together. https://t.co/lUj24LvYUZ
#Genomics#NSGC#Innovation
Baylor Genetics is hiring an Assistant/Associate Clinical Director of Clinical Reporting to lead genomic data interpretation and reporting. Help drive quality, innovation, and impact in precision diagnostics.
Apply now: https://t.co/N1smrZWDPe
#Hiring#RemoteWork
Today, we honor the strength and resilience of cancer survivors everywhere.
Behind every survivor is a journey filled with courage, hope, and the unwavering support of loved ones and care teams.
Your story matters and today we celebrate you.
#NationalCancerSurvivorsDay
Great conversations and insights at #FOGBoston this week. Dr. Christine Eng shared how multimodal approaches and advancing genomic technologies are driving more complete answers in rare disease diagnostics.
Learn more:
https://t.co/I9RtLvi894
#Genomics
Applauding NSGC, ASHG, & ACMG’s joint statement on the critical role of genetics in autism. With ~1 in 31 children affected & hundreds of genes identified, a genome-first approach is key to earlier insights & more informed care: https://t.co/EbX8EL9BzP
#Autism#AutismResearch
The future of genomics is on display today at #FOGBoston—Dr. Christine Eng shares how multimodal approaches are advancing rare disease diagnostics @ 2:40 PM ET @FLGenomics
Baylor Genetics’ Whole Genome Sequencing is expanding what’s possible in genomics:
https://t.co/FzP6yAfyms
Meet David Berger, Chief Legal Officer at Baylor Genetics. With 25+ years of experience, he leads legal & compliance strategy—driving growth, innovation, and expanded access to precision diagnostics while ensuring integrity at every step.
#Leadership#Genomics